Bone marrow transplantation for thalassemia

Early trials of allogeneic bone marrow transplantation (BMT) for homozygous beta-thalassemia and the analyses of results of transplantation in patients less then 16 years old have allowed us to identify three classes of risk using the criteria of degree of hepatomegaly, the degree of portal fibrosis...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Indian J Pediatr
Egile Nagusiak: Lucarelli, G., Angelucci, E., Giardini, C., Baronciani, D., Galimberti, M., Polchi, P., Erer, B.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer India 1993
Gaiak:
Symposium: Hematology/Oncology—II
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7102227/
https://ncbi.nlm.nih.gov/pubmed/8262588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/BF02751428
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak